Condensed Consolidated Statement of Noncontrolling Interests and Equity - USD ($) $ in Thousands | Total | Redemption of Operating Partnership units for cash | Preferred Operating Partnership | Operating Partnership | Operating PartnershipRedemption of Operating Partnership units for cash | Operating PartnershipRedemption of Operating Partnership units for stock | Other | Common Stock | Common StockRedemption of Operating Partnership units for stock | Additional Paid-in Capital | Additional Paid-in CapitalRedemption of Operating Partnership units for cash | Additional Paid-in CapitalRedemption of Operating Partnership units for stock | Accumulated Other Comprehensive Income | Accumulated Deficit |
Balance, beginning of period (in shares) at Dec. 31, 2017 | | | | | | | | 126,007,091 | | | | | | |
Balance, beginning of period at Dec. 31, 2017 | $ 2,723,807 | | $ 159,636 | $ 213,301 | | | $ 119 | $ 1,260 | | $ 2,569,485 | | | $ 33,290 | $ (253,284) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | | | | 31,525 | | | | | | |
Issuance of common stock upon the exercise of options | 799 | | | | | | | | | 799 | | | | |
Restricted stock grants issued (in shares) | | | | | | | | 31,136 | | | | | | |
Restricted stock grants canceled (in shares) | | | | | | | | (770) | | | | | | |
Compensation expense related to stock-based awards | 2,726 | | | | | | | | | 2,726 | | | | |
Repayment of receivable for preferred operating units pledged as collateral on loan | 495 | | 495 | | | | | | | | | | | |
Redemption of Operating Partnership units | | $ (2,558) | | | $ (1,126) | | | | | | $ (1,432) | | | |
Repurchase of equity portion of exchangeable senior notes | (21,000) | | | | | | | | | (21,000) | | | | |
Noncontrolling interest in consolidated joint venture | 122 | | | | | | 122 | | | | | | | |
Net income | 95,430 | | 3,390 | 3,784 | | | | | | | | | | 88,256 |
Other comprehensive income (loss) | 23,063 | | 144 | 938 | | | | | | | | | 21,981 | |
Distributions to Operating Partnership units held by noncontrolling interests | (7,909) | | (3,488) | (4,421) | | | | | | | | | | |
Dividends paid on common stock | (98,327) | | | | | | | | | | | | | (98,327) |
Balance, end of period (in shares) at Mar. 31, 2018 | | | | | | | | 126,068,982 | | | | | | |
Balance, end of period at Mar. 31, 2018 | 2,716,648 | | 160,177 | 212,476 | | | 241 | $ 1,260 | | 2,550,578 | | | 55,271 | (263,355) |
Balance, beginning of period (in shares) at Dec. 31, 2017 | | | | | | | | 126,007,091 | | | | | | |
Balance, beginning of period at Dec. 31, 2017 | 2,723,807 | | 159,636 | 213,301 | | | 119 | $ 1,260 | | 2,569,485 | | | 33,290 | (253,284) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | |
Net income | 337,830 | | | | | | | | | | | | | |
Balance, end of period (in shares) at Sep. 30, 2018 | | | | | | | | 126,504,802 | | | | | | |
Balance, end of period at Sep. 30, 2018 | 2,770,094 | | 160,250 | 213,885 | | | 240 | $ 1,264 | | 2,581,158 | | | 68,362 | (255,065) |
Balance, beginning of period (in shares) at Mar. 31, 2018 | | | | | | | | 126,068,982 | | | | | | |
Balance, beginning of period at Mar. 31, 2018 | 2,716,648 | | 160,177 | 212,476 | | | 241 | $ 1,260 | | 2,550,578 | | | 55,271 | (263,355) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | | | | 23,050 | | | | | | |
Issuance of common stock upon the exercise of options | 371 | | | | | | | $ 1 | | 370 | | | | |
Restricted stock grants issued (in shares) | | | | | | | | 50,334 | | | | | | |
Restricted stock grants canceled (in shares) | | | | | | | | (6,311) | | | | | | |
Compensation expense related to stock-based awards | 3,116 | | | | | | | | | 3,116 | | | | |
Redemption of Operating Partnership units (in shares) | | | | | | | | | 10,000 | | | | | |
Redemption of Operating Partnership units | | | | | | $ (383) | | | | | | $ 383 | | |
Issuance of Operating Partnership units in conjunction with acquisitions | 1,877 | | | 1,877 | | | | | | | | | | |
Net income | 102,713 | | 3,492 | 4,068 | | | | | | | | | | 95,153 |
Other comprehensive income (loss) | 8,033 | | 50 | 324 | | | | | | | | | 7,659 | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,468) | | (3,615) | (4,853) | | | | | | | | | | |
Dividends paid on common stock | (108,486) | | | | | | | | | | | | | (108,486) |
Balance, end of period (in shares) at Jun. 30, 2018 | | | | | | | | 126,146,055 | | | | | | |
Balance, end of period at Jun. 30, 2018 | 2,715,804 | | 160,104 | 213,509 | | | 241 | $ 1,261 | | 2,554,447 | | | 62,930 | (276,688) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | |
Restricted stock grants issued (in shares) | | | | | | | | 2,794 | | | | | | |
Restricted stock grants canceled (in shares) | | | | | | | | (2,298) | | | | | | |
Issuance of common stock, net of offering costs (in shares) | | | | | | | | 343,251 | | | | | | |
Issuance of common stock, net of offering costs | 33,780 | | | | | | | $ 3 | | 33,777 | | | | |
Compensation expense related to stock-based awards | 2,613 | | | | | | | | | 2,613 | | | | |
Redemption of Operating Partnership units (in shares) | | | | | | | | | 15,000 | | | | | |
Redemption of Operating Partnership units | | | | | | (572) | | | | | | 572 | | |
Repurchase of equity portion of exchangeable senior notes | 10,251 | | | | | | | | | 10,251 | | | | |
Net income | 139,687 | | 3,723 | 5,547 | | | (1) | | | | | | | 130,418 |
Other comprehensive income (loss) | 5,716 | | 39 | 245 | | | | | | | | | 5,432 | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,460) | | (3,616) | (4,844) | | | | | | | | | | |
Dividends paid on common stock | (108,795) | | | | | | | | | | | | | (108,795) |
Balance, end of period (in shares) at Sep. 30, 2018 | | | | | | | | 126,504,802 | | | | | | |
Balance, end of period at Sep. 30, 2018 | $ 2,770,094 | | 160,250 | 213,885 | | | 240 | $ 1,264 | | 2,581,158 | | | 68,362 | (255,065) |
Balance, beginning of period (in shares) at Dec. 31, 2018 | 127,103,750 | | | | | | | 127,103,750 | | | | | | |
Balance, beginning of period at Dec. 31, 2018 | $ 2,785,422 | | 153,096 | 218,362 | | | 240 | $ 1,271 | | 2,640,705 | | | 34,650 | (262,902) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | | | | 169,021 | | | | | | |
Issuance of common stock upon the exercise of options | 1,757 | | | | | | | $ 3 | | 1,754 | | | | |
Restricted stock grants issued (in shares) | | | | | | | | 35,022 | | | | | | |
Restricted stock grants canceled (in shares) | | | | | | | | (1,244) | | | | | | |
Compensation expense related to stock-based awards | 2,954 | | | | | | | | | 2,954 | | | | |
Redemption of Operating Partnership units (in shares) | | | | | | | | | 85,501 | | | | | |
Redemption of Operating Partnership units | | | | | | (3,310) | | | | | | 3,310 | | |
Issuance of Operating Partnership units in conjunction with acquisitions | 23,447 | | 23,447 | | | | | | | | | | | |
Net income | 102,160 | | 3,164 | 4,235 | | | (9) | | | | | | | 94,770 |
Other comprehensive income (loss) | (23,993) | | (147) | (1,003) | | | | | | | | | (22,843) | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,412) | | (3,296) | (5,116) | | | | | | | | | | |
Dividends paid on common stock | (109,523) | | | | | | | | | | | | | (109,523) |
Balance, end of period (in shares) at Mar. 31, 2019 | | | | | | | | 127,392,050 | | | | | | |
Balance, end of period at Mar. 31, 2019 | $ 2,773,812 | | 176,264 | 213,168 | | | 231 | $ 1,274 | | 2,648,723 | | | 11,807 | (277,655) |
Balance, beginning of period (in shares) at Dec. 31, 2018 | 127,103,750 | | | | | | | 127,103,750 | | | | | | |
Balance, beginning of period at Dec. 31, 2018 | $ 2,785,422 | | 153,096 | 218,362 | | | 240 | $ 1,271 | | 2,640,705 | | | 34,650 | (262,902) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | |
Net income | $ 330,844 | | | | | | | | | | | | | |
Balance, end of period (in shares) at Sep. 30, 2019 | 129,410,093 | | | | | | | 129,410,093 | | | | | | |
Balance, end of period at Sep. 30, 2019 | $ 2,907,989 | | 175,918 | 209,011 | | | 346 | $ 1,294 | | 2,861,611 | | | (43,439) | (296,752) |
Balance, beginning of period (in shares) at Mar. 31, 2019 | | | | | | | | 127,392,050 | | | | | | |
Balance, beginning of period at Mar. 31, 2019 | 2,773,812 | | 176,264 | 213,168 | | | 231 | $ 1,274 | | 2,648,723 | | | 11,807 | (277,655) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | | | | 17,042 | | | | | | |
Issuance of common stock upon the exercise of options | 468 | | | | | | | | | 468 | | | | |
Restricted stock grants issued (in shares) | | | | | | | | 53,789 | | | | | | |
Restricted stock grants issued | 2 | | | | | | | $ 2 | | | | | | |
Restricted stock grants canceled (in shares) | | | | | | | | (4,786) | | | | | | |
Issuance of common stock, net of offering costs (in shares) | | | | | | | | 930,000 | | | | | | |
Issuance of common stock, net of offering costs | 98,796 | | | | | | | $ 9 | | 98,787 | | | | |
Compensation expense related to stock-based awards | 3,998 | | | | | | | | | 3,998 | | | | |
Redemption of Operating Partnership units (in shares) | | | | | | | | | 125,000 | | | | | |
Redemption of Operating Partnership units | | | | | | (4,823) | | | | | | 4,823 | | |
Issuance of Operating Partnership units in conjunction with acquisitions | 4,575 | | 4,575 | | | | | | | | | | | |
Noncontrolling interest in consolidated joint venture | 50 | | | | | | 50 | | | | | | | |
Conversion of Preferred C Units in the Operating Partnership for Common Operating Partnership Units | | | (4,374) | 4,374 | | | | | | | | | | |
Net income | 112,689 | | 3,129 | 4,754 | | | (22) | | | | | | | 104,828 |
Other comprehensive income (loss) | (41,302) | | (254) | (1,765) | | | | | | | | | (39,283) | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,705) | | (3,232) | (5,473) | | | | | | | | | | |
Dividends paid on common stock | (115,572) | | | | | | | | | | | | | (115,572) |
Balance, end of period (in shares) at Jun. 30, 2019 | | | | | | | | 128,513,095 | | | | | | |
Balance, end of period at Jun. 30, 2019 | 2,828,811 | | 176,108 | 210,235 | | | 259 | $ 1,285 | | 2,756,799 | | | (27,476) | (288,399) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | | | | 14,850 | | | | | | |
Issuance of common stock upon the exercise of options | 605 | | | | | | | | | 605 | | | | |
Restricted stock grants issued (in shares) | | | | | | | | 5,099 | | | | | | |
Restricted stock grants issued | 0 | | | | | | | $ 0 | | | | | | |
Restricted stock grants canceled (in shares) | | | | | | | | (1,269) | | | | | | |
Issuance of common stock, net of offering costs (in shares) | | | | | | | | 849,200 | | | | | | |
Issuance of common stock, net of offering costs | 100,056 | | | | | | | $ 9 | | 100,047 | | | | |
Compensation expense related to stock-based awards | 3,035 | | | | | | | | | 3,035 | | | | |
Repayment of receivable for preferred operating units pledged as collateral on loan | 1,211 | | | 1,211 | | | | | | | | | | |
Redemption of Operating Partnership units (in shares) | | | | | | | | | 29,118 | | | | | |
Redemption of Operating Partnership units | | | | | | $ (1,125) | | | | | | $ 1,125 | | |
Noncontrolling interest in consolidated joint venture | 96 | | | | | | 96 | | | | | | | |
Net income | 115,995 | | 3,089 | 4,828 | | | (9) | | | | | | | 108,087 |
Other comprehensive income (loss) | (16,762) | | (101) | (698) | | | | | | | | | (15,963) | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,618) | | (3,178) | (5,440) | | | | | | | | | | |
Dividends paid on common stock | $ (116,440) | | | | | | | | | | | | | (116,440) |
Balance, end of period (in shares) at Sep. 30, 2019 | 129,410,093 | | | | | | | 129,410,093 | | | | | | |
Balance, end of period at Sep. 30, 2019 | $ 2,907,989 | | $ 175,918 | $ 209,011 | | | $ 346 | $ 1,294 | | $ 2,861,611 | | | $ (43,439) | $ (296,752) |